本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Axsome Therapeutics, Inc.

127.94
+2.942.35%
盘后127.940.00000.00%18:06 EDT
成交量:34.66万
成交额:4,398.47万
市值:63.84亿
市盈率:-25.26
高:128.23
开:124.18
低:124.18
收:125.00
52周最高:139.13
52周最低:75.56
股本:4,990.15万
流通股本:4,187.28万
量比:0.73
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-5.0644
每股收益(LYR):-5.9944
净资产收益率:-280.68%
总资产收益率:-21.90%
市净率:87.37
市盈率(LYR):-21.34

数据加载中...

2025/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

重要事件披露

Form 8-K - Current report
2025/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities